✦ LIBER ✦

Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone

✍ Scribed by S. E. Park; E. S. Kang; D. H. Kim; S. K. Kim; J. H. Lee; C. W. Ahn; H. C. Lee; B. S. Cha

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ABCA1 variants on rosiglitazo

✍ Jie WANG; Yu-qian BAO; Cheng HU; Rong ZHANG; Cong-rong WANG; Jun-xi LU; Wei-ping 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 Chinese ⚖ 293 KB

Alternate-day dosing of atorvastatin: ef

✍ J C. Ferrer-García; J. Pérez-Silvestre; I. Martínez-Mir; A. Herrera-Ballester 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 73 KB

Metabolic effects of telmisartan and irb

✍ G. Derosa; E. Fogari; A. D'Angelo; A. F. G. Cicero; S. A. T. Salvadeo; P. D. Rag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Enhancement of insulin-stimulated myocar

✍ K. Hällsten; K. A. Virtanen; F. Lönnqvist; T. Janatuinen; M. Turiceanu; T. Rönne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

The therapeutic efficacy of rosiglitazon

✍ H. Itakura; F. Abbasi; C. Lamendola; M. Basina; G. Reaven 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Beneficial effects of rosiglitazone on n

✍ N. P. E. Kadoglou; F. Iliadis; N. Angelopoulou; D. Perrea; C. D. Liapis; M. Alev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB